Sep 22, 2026 8 0
Uploaded by PakDamar76
Favorite
Share
More Options
12
A phase 1 study of PF-07260437, a B7-H4 × CD3 bispecific T-cell engager, in patients with advanced or metastatic breast, ovarian, and endometrial cancer_Page 1

Open in WPS to view all 12 pages